YPrime logo

YPrime

eCOA, IRT, and eConsent technology for clinical trial sponsors and CROs, enabling faster startup, data quality, and regulatory compliance across global studies.

Visit website

Overview

YPrime is a global clinical trial technology company that delivers an integrated eClinical platform purpose-built for sponsors and CROs executing complex, large-scale studies. Founded in 2006 and operating across more than 100 countries, YPrime combines configurable eCOA, IRT, and eConsent solutions with expert consulting and 24/7/365 operational support to help clinical trial teams move faster, maintain data integrity, and achieve inspection-ready oversight from study startup through data lock.

YPrime serves top pharmaceutical companies, emerging biotechs, and CROs across more than 19 therapeutic areas—including oncology, rare disease, CNS, cardiometabolic, vaccines, and ophthalmology. With approximately 1,000 studies implemented globally, over 125,000 patients engaged, and more than 16 years of eClinical technology and services experience, YPrime has established itself as a trusted partner for simplifying the complexity of global clinical development.

Core Platform Solutions

  • eCOA (Electronic Clinical Outcome Assessment): An enterprise-grade platform that accelerates study startup timelines by approximately 50% while improving data quality and regulatory compliance. The platform is highly configurable using pre-validated code, enabling rapid deployment without sacrificing oversight.
  • IRT (Interactive Response Technology): An industry-leading platform designed to support complex trial designs and rapid protocol updates without creating operational bottlenecks. IRT startup times are significantly faster, and protocol amendments are handled more smoothly compared to traditional approaches.
  • eConsent: An intuitive electronic consent solution that streamlines participant enrollment, improves patient understanding of study requirements, and reduces administrative burden on clinical research sites.
  • Patient Engagement: Integrated participant-engagement workflows that complement eCOA, IRT, and eConsent to support a more connected and patient-centric trial experience.

Key Platform Capabilities

  • Speed: Accelerates clinical trial startup, mid-study changes, and global execution across all core eClinical modules.
  • Flexibility: Configurable architecture allows teams to adapt protocols, strategies, and study designs without disruption, supporting today's adaptive clinical trial models.
  • Oversight: Ensures inspection-ready data, traceable workflows, and accountable review processes across eCOA, IRT, and eConsent functions.
  • Integrated data flows: Consistent global delivery with integrated data workflows that enable data quality at every step of the clinical trial lifecycle.
  • Data standards expertise: YPrime's data science team actively helps construct data standards for individual studies, a capability noted as distinctive within the eCOA industry.

Operational Support and Services

  • 24/7/365 global help desk staffed by eClinical experts who are knowledgeable about individual protocols and workflows across eCOA, IRT, and eConsent.
  • Direct access to expert support teams for sponsors, CROs, and clinical research sites to keep trials on track.
  • Real-time issue resolution, transparent communication, and visibility into performance metrics to maintain data integrity and site confidence.
  • Support is embedded within the platform architecture rather than treated as a separate service layer.

Clinical Trial Consulting

  • Expert consulting services that extend the YPrime technology platform with strategic and operational guidance.
  • Optimization of clinical trial processes to reduce risk and improve execution efficiency.
  • Alignment of technology solutions with protocol requirements and regulatory standards.
  • Integration of systems and data workflows across the clinical trial ecosystem.
  • Transformation of operational data into actionable insights to support decision-making and inspection readiness.

Leadership and Company Background

  • YPrime was co-founded in 2006 by Shawn Blackburn, who grew the company from a two-person consultancy into a global clinical trial technology provider. Blackburn previously held technology consulting roles at Cephalon and Parexel.
  • Steve Begley, Chief Compliance Officer, oversees corporate privacy strategy, data protection, global quality functions, regulatory compliance, and quality management systems. He brings prior experience from Cenduit, ePharma Solutions, and Clarix/Phase Forward (Oracle).
  • Mohan Ganesan, Chief Financial Officer, brings more than 20 years of finance leadership in life sciences, including prior CFO experience at Amplity Health, with responsibility for finance, accounting, and business operations.
  • Lindsay Daniel, Chief Human Resources Officer, leads people strategy, talent management, and organizational development, drawing on more than 15 years of experience across financial services, healthcare, and life sciences, including roles at Macquarie Group and The Advisory Board Company.

YPrime's combination of configurable eClinical technology, embedded operational support, and expert consulting makes it a comprehensive partner for sponsors and CROs seeking to execute global clinical trials with greater speed, flexibility, and confidence.